FDA Breakthrough Therapy Designation for investigational treatment in cognitive impairment associated with Schizophrenia
FDA Breakthrough Therapy Designation for investigational treatment in cognitive impairment associated with Schizophrenia
FDA Breakthrough Therapy Designation for investigational treatment in cognitive impairment associated with Schizophrenia